Hildy Sastre's record includes successfully defending Sanofi-Aventis in two bellwether trials over its chemotherapy drug ...

Drugmaker Sanofi-Aventis employs 100,000 people worldwide, but it is the 66 employees at its Oro Valley research center who have developed about half of the company's drug compounds. The ...

Sanofi-Aventis is buying specialty drug maker Genzyme for $20.1 billion, the latest example of a beleaguered pharmaceutical company snapping up high-priced biotech drugs to offset dwindling sales of ...

Neurologists and health care practitioners must evolve with the world. Telemedicine carts assist in this evolution by serving as an intermediary between patients and doctors.

(RTTNews) - Sanofi-Aventis Groupe announced positive results from the pivotal LUNA 3 phase 3 study of rilzabrutinib in adults with persistent or chronic immune thrombocytopenia (ITP), a rare ...

On Feb. 14, the agency approved the drug, a biosimilar to Novolog, for glycemic control improvement in adult and pediatric diabetic patients. The subcutaneous medication is approved in a 3 milliliter, ...

(RTTNews) - Sanofi - Aventis Groupe said that the data featured at IDWeek from several national immunization programs will reinforce the proven efficacy and favorable safety profile of Beyfortus ...

Emphasizing the tenet that antitrust laws are enacted to protect ­competition—and not competitors—the Third Circuit has rejected one competitor's claim that Sanofi-Aventis had an unfair advantage in ...

The positions in the table below reflect the Sanofi-Aventis Deutschland GmbH's position overall, domestically, within their sector, and in various subject areas based on their Share. Each position ...

BARCELONA/PARIS, Nov 16 (Reuters) - French advertising group Havas said on Thursday it had poached work from larger rival Publicis related to pharmaceutical company Sanofi-Aventis . Sign up here.